1
Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression
Condition(s):Bipolar Depression; Treatment Effectiveness; Measure-based GuidanceLast Updated:June 26, 2018Unknown status
OXCARBAZEPINE: 81 Clinical Trials, Page 1 of 9
Hide Studies Not Open or Pending
2
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain
Condition(s):Polyneuropathy; Peripheral Nerve Injury; Postherpetic NeuralgiaLast Updated:May 5, 2014Completed
3
Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Condition(s):EpilepsyLast Updated:January 8, 2015Completed
4
Protective Role of Oxcarbazepine in Multiple Sclerosis
Condition(s):Multiple SclerosisLast Updated:April 18, 2018Completed
5
Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
Condition(s):Bipolar DisorderLast Updated:May 7, 2019Completed
6
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
Condition(s):SeizuresLast Updated:January 23, 2018Completed
7
Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Condition(s):CancerLast Updated:January 31, 2017Terminated
8
Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Condition(s):EpilepsyLast Updated:January 1, 2015Completed
9
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
Condition(s):SeizuresLast Updated:January 23, 2018Completed
10
Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia
Condition(s):Trigeminal NeuralgiaLast Updated:November 1, 2019Withdrawn